Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 4,895 shares at $123.72 ($611K) on 2018-07-18, disclosed to the SEC on 2018-09-21.
Open-market sale of $611k ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.72 | 1,185 | $147K | 24.0% |
| 2 | $123.72 | 1,185 | $147K | 24.0% |
| 3 | $125.60 | 1,621 | $204K | 33.3% |
| 4 | $126.40 | 904 | $114K | 18.7% |
| Total | $124.84 avg | 4,895 | $611K | 100% |
| Filing → |
| ENTA | SELL | 2022-01-13 | $1.8M | — | Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |